
Inside Aesthetics Ep 77 What Are Stem Cells and How Can They Be Used to Treat Us? | Dr Neil Neimark
Episode 77 hosts Dr Neil Neimark (Functional medicine doctor from California, USA)
Since becoming a doctor, Dr Neimark has worked using a holistic approach that aims to harness the bodies own capacity to heal itself.
He is one of America's most experienced doctors in using stem cells. This is a pioneering new treatment modality that has shown great promise in healing a variety of common issues that are traditionally treated pharmacologically, surgically or cannot be helped conventionally.
0:00 Introduction 1:03 Meet Dr Neil Neimark 3:19 Background in Preventive and Functional Medicine 5:16 Frustration With Symptom Based Healthcare 9:44 What Is Functional Medicine 11:56 Systems Approach to Disease 14:01 Moving Into Stem Cell Therapy 16:30 IV Therapy and Regenerative Medicine 18:16 Anti Inflammatory and Healing Mechanisms 23:53 Early Stem Cell Patient Cases 27:02 Treating Pain and Inflammation 30:22 Liposuction and Stem Cell Harvesting 33:44 How Stem Cells Are Cultured 37:39 Autologous vs Umbilical Stem Cells 41:39 Regulatory Differences and Access 45:36 Cost and Treatment Protocols 48:05 Longevity of Results and Boosters 51:43 Treating Arthritis and Joint Conditions 57:32 Autoimmune Disease Applications 1:01:04 Stroke and Brain Injury Potential 1:03:30 Blood Vessel Growth and Healing 1:07:48 IV vs Local Injection Decisions 1:12:19 Evidence and Clinical Outcomes 1:16:00 Success Rates and Limitations 1:19:56 Cost Considerations and Patient Expectations 1:22:22 Avoiding Unethical Providers 1:25:07 Common Treatment Indications 1:27:43 PRP and Regenerative Add On Therapies 1:30:37 Risks and Safety Considerations 1:33:59 Cosmetic and Wound Healing Uses 1:36:53 Future Applications and Organ Regeneration 1:39:25 Preventing Amputation and Vascular Disease 1:42:10 Insurance and Healthcare Economics 1:44:30 Availability in Different Countries 1:48:40 Stem Cells in Skincare Discussion 1:53:30 Realistic Expectations and Evidence 1:55:45 Contact Details and Closing Remarks
